Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
LabGenius Therapeutics
LabGenius develops next-generation antibody and protein therapeutics to improve selectivity and tumor cell killing. The company applies a machine learning–driven evolution engine (EVA) that combines…
LabGenius Therapeutics
LabGenius develops next-generation antibody and protein therapeutics to improve selectivity and tumor cell killing. The company applies a machine learning–driven evolution engine (EVA) that combines…
TL;DR
Headquarters & founding: London; founded 2012
Core tech: EVA™ — ML-driven discovery engine combining machine learning, synthetic biology, and robotic automation
Focus: Discovery and optimisation of therapeutic antibodies for oncology (selectivity-enhanced antibodies, multispecific formats, T-cell engagers)
Recent financing: Series B £35M closed May 21, 2024 (led by M Ventures); company-reported total funding ~£58M
Company Overview
Problem Domain
Therapeutic antibody discovery and optimisation for oncology
Founded
2012
Industry
Biotechnology Research
Tech Stack
Funding Track Record
£35,000,000
Company reported this round brought total funding to ~£58M
Investor Signal
“Includes corporate VC and top-tier venture investors (M Ventures lead; participation from Octopus Ventures, LG, Atomico, Kindred Capital, Lux Capital, Obvious Ventures)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |